Biosimilar IPR List and Status Update

AIA Review#

Filing Date

Institution Decision Date

Petitioner

Patent No.

PO/Respondent

Status

IPR2015-01514

06/26/2015

01/14/2016

Amgen Inc

8916157

AbbVie Biotechnology Ltd.

Terminated

IPR2015-01517

06/26/2015

01/14/2016

Amgen Inc

8916158

AbbVie Biotechnology Ltd.

Terminated

IPR2016-00172

11/09/2015

05/17/2016

Coherus BioSciences Inc.

8889135

AbbVie Biotechnology Ltd.

Trial Instituted

IPR2016-00188

12/07/2015

06/13/2016

Coherus BioSciences Inc.

9017680

AbbVie Biotechnology Ltd.

Trial Instituted

IPR2016-00189

12/07/2015

06/13/2016

Coherus BioSciences Inc.

9073987

AbbVie Biotechnology Ltd.

Trial Instituted

IPR2016-00408

12/29/2015

07/07/2016

Boehringer Ingelheim GmbH

8889135

AbbVie Biotechnology Ltd.

Trial Instituted

IPR2016-00409

12/29/2015

07/07/2016

Boehringer Ingelheim GmbH

8889135

AbbVie Biotechnology Ltd.

Trial Instituted

IPR2016-01018

05/09/2016

11/07/2016

Coherus BioSciences Inc.

9114166

AbbVie Biotechnology Ltd.

Terminated

IPR2017-00822

01/31/2017

Coherus BioSciences, Inc.

9085619

AbbVie Biotechnology Ltd.

Pending

IPR2017-00823

01/31/2017

Coherus BioSciences, Inc.

9085619

AbbVie Biotechnology Ltd.

Pending

IPR2017-00826

01/31/2017

Coherus BioSciences, Inc.

9085619

AbbVie Biotechnology Ltd.

Pending

IPR2017-00827

01/31/2017

Coherus BioSciences Inc.

9085619

AbbVie Biotechnology Ltd.

Pending

IPR2017-01008

03/02/2017

Coherus BioSciences Inc.

9085619

AbbVie Biotechnology Ltd.

Pending

IPR2017-01009

03-02/2017

Coherus BioSciences Inc.

9085619

AbbVie Biotechnology Ltd.

Pending

IPR2016-01542

08/05/2016

02/17/2017

Apotex Inc.

8952138

Amgen Inc.

Trial Instituted

IPR2015-00418

12/15/2014

07/13/2015

Boehringer Ingelheim Pharmaceuticals, Inc.

8329172

Biogen Inc.

Terminated

IPR2016-00912

04/18/2016

10/17/2016

Swiss Pharma International AG

8815236

Biogen MA Inc.

Institution Denied

IPR2016-00915

04/18/2016

10/17/2016

Swiss Pharma International AG

8349321

Biogen MA Inc.

Institution Denied

IPR2016-00916

04/18/2016

10/17/2016

Swiss Pharma International AG

8900577

Biogen MA Inc.

Institution Denied

IPR2016-01614

08/15/2016

02/24/2017

Celltrion, Inc.

7820161

Genentech, Inc. [Biogen, Inc.]

Trial Instituted

IPR2017-01093

03/15/2017

Celltrion Inc.

8329172

BIOGEN INC.

Pending

IPR2017-01094

03/15/2017

Celltrion Inc.

8557244

BIOGEN INC.

Pending

IPR2017-01095

03/15/2017

Celltrion Inc.

9296821

BIOGEN INC.

Pending

IPR2015-01537

07/02/2015

01/15/2016

Momenta Pharmaceuticals, Inc.

8476239

Bristol-Myers Squibb Company

Final Written Decision

IPR2015-00415

12/15/2014

07/17/2015

Boehringer Ingelheim Pharmaceuticals, Inc.

7820161

Genentech, Inc.

Terminated

IPR2015-00417

12/15/2014

07/14/2015

Boehringer Ingelheim Pharmaceuticals, Inc.

7976838

Genentech, Inc.

Terminated

IPR2015-01624

07/27/2015

02/05/2016

Sanofi-Aventis U.S. LLC

6331415

Genentech, Inc.

Terminated

IPR2015-01733

08/14/2015

10/06/2015

Celltrion, Inc.

7976838

Genentech, Inc.

Institution Denied

IPR2015-01744

08/17/2015

10/06/2015

Celltrion, Inc.

7820161

Genentech, Inc.

Institution Denied

IPR2016-00383

12/30/2015

06/23/2016

GENZYME CORPORATION

6331415

Genentech Inc.

Terminated

IPR2016-00460

01/15/2016

06/08/2016

Genzyme Corporation

6331415

GENENTECH, INC.

Terminated

IPR2016-00710

03/03/2016

09/08/2016

Mylan Pharmaceuticals Inc.

6331415

Genentech, Inc.

Trial Instituted

IPR2016-01373

07/07/2016

01/03/2017

Merck Sharp & Dohme Corp.

6331415

Genentech, Inc.

Institution Denied

IPR2016-01608

08/16/2016

bioeq IP AG

6716602

GENENTECH, INC.

Terminated

IPR2016-01667

08/24/2016

03/02/2017

Celltrion Inc.

7976838

Genentech, Inc.

Institution Denied

IPR2016-01693

08/30/2016

Mylan Pharmaceuticals Inc.

6407213

Genentech, Inc.

Terminated

IPR2016-01694

08/30/2016

Mylan Pharmaceuticals Inc.

6407213

Genentech, Inc.

Terminated

IPR2016-01771

09/09/2016

03/16/2017

Hospira, Inc.

7622115

Genentech, Inc.

Trial Instituted

IPR2016-01837

09/16/2016

03/15/2017

Hospira, Inc.

7807799

Genentech, Inc.

Trial Instituted

IPR2017-00047

10/11/2016

01/03/2017

Merck Sharp & Dohme Corp.

6331415

Genentech, Inc.

Terminated

IPR2017-00731

01/20/2017

Hospira, Inc.

7846441

Genentech, Inc.

Pending

IPR2017-00737

01/20/2017

Hospira, Inc.

7892549

Genentech, Inc.

Pending

IPR2017-00739

01/20/2017

Hospira, Inc.

7892549

Genentech, Inc.

Pending

IPR2017-00804

01/30/2017

Hospira, Inc.

6627196

Genentech, Inc.

Pending

IPR2017-00805

01/30/2017

Hospira, Inc.

7371379

Genentech, Inc.

Pending

IPR2017-00959

02/21/2017

Celltrion, Inc.

8591897

Genentech, Inc.

Pending

IPR2017-01121

03/21/2017

Celltrion, Inc.

7846441

Genentech, Inc.

Pending

IPR2017-01122

03/21/2017

Celltrion, Inc.

7892549

Genentech, Inc.

Pending

IPR2015-01792

08/22/2015

03/11/2016

Coalition for Affordable Drugs V LLC

8163522

Hoffmann-La Roche Inc.

Terminated

IPR2014-00676

04/22/2014

10/29/2014

Phigenix, Inc.

8337856

ImmunoGen, Inc.

Final Written Decision

IPR2014-00842

05/29/2014

12/09/2014

Phigenix, Inc.

7575748

ImmunoGen, Inc.

Terminated

IPR2013-00365

06/19/2013

10/24/2013

Hospira, Inc.

6747002

Janssen Pharmaceuticals, Inc.

Institution Denied

IPR2015-00990

04/01/2015

10/23/2015

Coalition for Affordable Drugs II LLC

7056886

NPS Pharmaceuticals, Inc.

Final Written Decision

IPR2015-01093

04/23/2015

10/23/2015

Coalition for Affordable Drugs II, LLC

7056886

NPS Pharmaceuticals, Inc.

Final Written Decision

IPR2016-00258

11/25/2015

05/25/2016

Green Cross Corporation

9051556

Shire Human Genetic Therapies, Inc.

Final Written Decision